Cargando…
Regulatory B cells: TIM‐1, transplant tolerance, and rejection
Regulatory B cells (Bregs) ameliorate autoimmune disease and prevent allograft rejection. Conversely, they hinder effective clearance of pathogens and malignancies. Breg activity is mainly attributed to IL‐10 expression, but also utilizes additional regulatory mechanisms such as TGF‐β, FasL, IL‐35,...
Autores principales: | Cherukuri, Aravind, Mohib, Kanishka, Rothstein, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968891/ https://www.ncbi.nlm.nih.gov/pubmed/33484008 http://dx.doi.org/10.1111/imr.12933 |
Ejemplares similares
-
B Cell IL-4 Drives Th2 Responses In Vivo, Ameliorates Allograft Rejection, and Promotes Allergic Airway Disease
por: Song, Zhixing, et al.
Publicado: (2022) -
Future prospects for CD8(+) regulatory T cells in immune tolerance
por: Flippe, Léa, et al.
Publicado: (2019) -
The expanding family of regulatory B cells
por: Mauri, Claudia, et al.
Publicado: (2015) -
Regulatory B cells in respiratory health and diseases
por: Menon, Madhvi, et al.
Publicado: (2021) -
The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function
por: Boller, Sören, et al.
Publicado: (2014)